Form EFFECT LogicMark, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 16, 2026 |
| Accession Number: | 0001213900-26-109846 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pancreatic Cancer Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeut
- Bayhorse Silver Expands The Known Silver Mineralized Rhyolite Zone And Has Conducted a Multi Spectrum Satellite Analysis Of Its Bayhorse and Pegasus Properties
- NetworkNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) to Present Updated Phase 1a TTX-MC138 Clinical Data at ESMO Congress 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share